35 investors have funded 8 Life Sciences Tech companies head-officed in Shenzhen, across 45 rounds (Jun 2015 – Mar 2026). They are ranked by how many Shenzhen companies in this market they have actually backed.
"In Shenzhen" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | Gaorong Capital | Beijing, China | Series BSeries A | 1 | 4 | 2 | Dec 2021 | 203 |
| 2 | 5Y Capital | Shanghai, China | Series BSeries A | 1 | 4 | — | Dec 2021 | 154 |
| 3 | Legend Capital | Haidian, China | Series B | 1 | 3 | 1 | Dec 2021 | 335 |
| 4 | Primavera | Beijing, China | Series B | 1 | 2 | 1 | Dec 2021 | 61 |
| 5 | Vcanbio Cell & Gene Engineering Corporation | Tianjin, China | Series A | 1 | 2 | 1 | Apr 2016 | 2 |
| 6 | Tencent | Shenzhen, China | Series A | 1 | 1 | 1 | Apr 2016 | 685 |
| 7 | IDG Capital | New York City, United States | Series B | 1 | 1 | 1 | Dec 2018 | 636 |
| 8 | Zhen Fund | Beijing, China | Series A | 1 | 1 | 1 | Aug 2018 | 412 |
| 9 | Puhua Capital | Hangzhou, China | Seed | 1 | 1 | — | Mar 2018 | 120 |
| 10 | Tiantu Capital | Shenzhen | Series B | 1 | 1 | — | Dec 2021 | 75 |
| 11 | Sky9 Capital | Shanghai, China | Series B | 1 | 1 | — | Dec 2021 | 68 |
| 12 | HSG | Hong Kong, China | Angel | 1 | 1 | 1 | Oct 2025 | 61 |
| 13 | HLC | Shanghai, China | Seed | 1 | 1 | 1 | Mar 2021 | 43 |
| 14 | Yijing Capital | Shanghai, China | Seed | 1 | 1 | — | Mar 2021 | 34 |
| 15 | Medfine Capital | Beijing, China | Seed | 1 | 1 | — | Mar 2021 | 29 |
| 16 | Shenzhen Chuangdong Investment | Shenzhen, China | Seed | 1 | 1 | — | 34 | |
| 17 | Hike Capital | Chaoyang, China | Series B | 1 | 1 | — | Dec 2021 | 24 |
| 18 | Hangzhou Kaitai Capital Management | Hangzhou, China | Series A | 1 | 1 | — | Jun 2015 | 24 |
| 19 | China Investment Corporation | Beijing, China | Series D | 1 | 1 | 1 | Apr 2021 | 18 |
| 20 | Shenzhen Nanshan Strategic Emerging Industries Investment | Shenzhen, China | Seed | 1 | 1 | — | Nov 2025 | 13 |
| 21 | FUHO Capital Management | Haidian, China | Series A | 1 | 1 | 1 | Nov 2024 | 8 |
| 22 | Tailong Investment | Hangzhou, China | Series A | 1 | 1 | — | Mar 2026 | 5 |
| 23 | Huada Gene | Shenzhen, China | Seed | 1 | 1 | — | Mar 2018 | 5 |
| 24 | Zhongying Venture Capital | Hangzhou, China | Series A | 1 | 1 | — | Mar 2026 | 3 |
| 25 | Wealthking Investments | Central, Hong Kong | Series A | 1 | 1 | 1 | Jun 2018 | 3 |
| 26 | Pharmaron | Beijing, China | Series A | 1 | 1 | — | Dec 2021 | 3 |
| 27 | Zhongshan Venture Capital | Series A | 1 | 1 | — | Mar 2026 | 3 | |
| 28 | China Money Network | Hong Kong, China | Series D | 1 | 1 | 1 | Apr 2021 | 2 |
| 29 | Fuhui Venture Capital | Series A | 1 | 1 | — | Mar 2026 | 2 | |
| 30 | China Bridge Capital | Chaoyang, China | Series A | 1 | 1 | 1 | Jul 2016 | 1 |
| 31 | Jingtai Technology | Series A | 1 | 1 | — | Nov 2024 | 1 | |
| 32 | Mining World Star | Series A | 1 | 1 | — | Mar 2026 | 1 | |
| 33 | Yahui Investment | Series A | 1 | 1 | — | Jun 2019 | 1 | |
| 34 | Junyiinvestment | Series A | 1 | 1 | — | Nov 2024 | 1 | |
| 35 | Mony Valley | Series A | 1 | 1 | — | Mar 2026 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences Tech companies head-officed in Shenzhen that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Xbiome xbiome.com |
9 | 18 | $722.5M | Series B Dec 2021 |
| Leman Biotech lemanbio.com |
9 | 9 | $215.9M | Series A Mar 2026 |
| ICarbonX icarbonx.com |
6 | 7 | $671.4M | Series D Apr 2021 |
| Artivila Therapeutics artivila.com |
3 | 3 | $68.5M | Seed Mar 2021 |
| Yuce Biotechnology yucebio.com |
3 | 3 | — | Series B Dec 2018 |
| OxTium Technology oxtium.com |
3 | 3 | — | Seed Nov 2025 |
| QY Genomics qygenomics.com |
1 | 1 | — | Series A Jun 2015 |
| Eclincloud eclincloud.com |
1 | 1 | — | Series A Dec 2021 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Mar 2026 | Fuhui Venture Capital | Leman Biotech | Series A | $29M |
| Mar 2026 | Zhongshan Venture Capital | Leman Biotech | Series A | $29M |
| Mar 2026 | Tailong Investment | Leman Biotech | Series A | $29M |
| Mar 2026 | Zhongying Venture Capital | Leman Biotech | Series A | $29M |
| Mar 2026 | Mining World Star | Leman Biotech | Series A | $29M |
| Mar 2026 | Mony Valley | Leman Biotech | Series A | $29M |
| Nov 2025 | Shenzhen Nanshan Strategic Emerging Industries Investment | OxTium Technology | Seed | — |
| Oct 2025 | HSGLED | OxTium Technology | Angel | — |
| Nov 2024 | FUHO Capital ManagementLED | Leman Biotech | Series A | $13.9M |
| Nov 2024 | Junyiinvestment | Leman Biotech | Series A | $13.9M |
| Nov 2024 | Jingtai Technology | Leman Biotech | Series A | $13.9M |
| Dec 2021 | Primavera | Xbiome | Series B | $100M |
| Dec 2021 | Legend Capital | Xbiome | Series B | $100M |
| Dec 2021 | Tiantu Capital | Xbiome | Series B | $100M |
| Dec 2021 | Hike Capital | Xbiome | Series B | $100M |
| Dec 2021 | Sky9 Capital | Xbiome | Series B | $100M |
| Dec 2021 | Gaorong CapitalLED | Xbiome | Series B | $100M |
| Dec 2021 | 5Y Capital | Xbiome | Series B | $100M |
| Dec 2021 | Pharmaron | Eclincloud | Series A | — |
| Apr 2021 | China Investment CorporationLED | ICarbonX | Series D | $151M |
Life Sciences Tech investors in other cities
Other markets in Shenzhen